The role of PON-2 and PON3 proteins in atherosclerosis

PON-2和PON3蛋白在动脉粥样硬化中的作用

• 批准号: 7643319
• 负责人: SRINIVASA T. Reddy
• 金额: $ 38.07万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-01-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7643319
• 关键词: Acute; Adenoviruses; Alzheimer' s Disease; Animal Model; Antiatherogenic; Antioxidants; Apolipoprotein E; Apolipoproteins B; Arterial Fatty Streak; Arts; Atherogenic Diet; Atherosclerosis; Bacterial Genes; Biological Models; Cell Culture Techniques; Cells; Chronic; Defect; Development; Diabetes Mellitus; Diet; Disease; Endothelial Cells; Enzymes; Event; Family member; Fatty acid glycerol esters; Gene Family; Genes; Gluconolactonase; Goals; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Grant; Hepatocyte; Host Defense; Human; Hydrolysis; Immune response; In Vitro; Infection; Inflammation; Inflammatory; Knock-out; Knockout Mice; Lactones; Lesion; Link; Lipid Peroxidation; Lipids; Lipoproteins; Low Density Lipoprotein oxidation; Malignant Neoplasms; Mediating; Methodology; Molecular; Mus; Paraoxonase-2; Parkinson Disease; Pathogenesis; Pathology; Pathway interactions; Phospholipids; Physiological; Physiology; Play; Property; Proteins; Pseudomonas aeruginosa; Reporter; Research Personnel; Risk Factors; Role; Secondary to; Signal Transduction; Testing; Time; Tissue Extracts; Transgenic Mice; Transgenic Organisms; Virulence; Virulence Factors; Work; airway epithelium; aryldialkylphosphatase; atherogenesis; density; homoserine lactone; improved; in vivo; macrophage; male; member; microbial; mouse model; novel; overexpression; oxidized low density lipoprotein; particle; pathogen; pathogenic bacteria; prevent; programs; quorum sensing; research study; sensor

DESCRIPTION (provided by applicant): The paraoxonase (PON) gene family consists of three family members, PON1, PON2 and PONS. PON genes are implicated in the pathogenesis of several inflammatory diseases including atherosclerosis. All three PON proteins possess antioxidant properties and lactonase activities; however, the physiological substrates for PON proteins and their mechanism of action remain unknown. Our long-term goal is to understand the role of PON2 and PONS proteins in physiology and disease. During the last grant period, we have developed transgenic/knockout mouse models for PON2 and PONS genes, and provided the first in vivo evidence for the anti-atherogenic functions of PON2 and PONS proteins. We have also demonstrated that oxidized phospholipids or lipid peroxidation products are not direct substrates for purified PON enzymes, suggesting that direct inactivation of atherogenic oxidized phospholipids is not a key mechanism of action of PON proteins. We propose that the anti-atherogenic activities of PON proteins are a result of their activity towards a class of unidentified pro-inflammatory lipo-lactones that participate in LDL oxidation. Interestingly, in a very exciting turn of events, we recently discovered that PON2 and PONS proteins degrade gram-negative bacterial density-dependent sensing molecules termed acyl homoserine lactones (AHL) involved in gram-negative virulence. AHLs are lipo-lactones. Since gram-negative virulence is well established in the pathology of inflammatory diseases, including atherosclerosis, we propose that protection against pro-inflammatory pathways mediated by gram-negative virulence factors, such as AHLs, and other unidentified pro-inflammatory lipo-lactones, is a key physiological function of PON proteins. We will test this hypothesis in PON2 and PONS transgenic/knockout mouse models under two specific aims to 1) investigate the molecular mechanisms and function of PON2 and PONS in mitigating the development of atherosclerosis and 2) determine whether PON2 and PONS play a role in host defense against pro-inflammatory quorum sensing molecules and gram-negative bacterial infection. We hypothesize that PON2 and PONS are a novel class of lactonases that degrade i) atherogenic lipo-lactones associated with atherosclerosis, and ii) pro-inflammatory acyl homoserine lactones associated with gram-negative bacteria, thus preventing the pathogenesis of inflammatory diseases.

描述（由申请人提供）：对氧磷酶（PON）基因家族由三个家族成员组成，即PON 1、PON 2和脑桥。PON基因与包括动脉粥样硬化在内的多种炎性疾病的发病机制有关。这三种PON蛋白都具有抗氧化特性和内酯酶活性;然而，PON蛋白的生理底物及其作用机制仍然未知。我们的长期目标是了解PON 2和脑桥蛋白在生理和疾病中的作用。在上一个资助期内，我们开发了PON 2和脑桥基因的转基因/敲除小鼠模型，并为PON 2和脑桥蛋白的抗动脉粥样硬化功能提供了第一个体内证据。我们还证明了氧化磷脂或脂质过氧化产物不是纯化PON酶的直接底物，这表明致动脉粥样硬化的氧化磷脂的直接失活不是PON蛋白作用的关键机制。我们提出PON蛋白的抗动脉粥样硬化活性是其对一类参与LDL氧化的未鉴定的促炎性脂内酯的活性的结果。有趣的是，在一个非常令人兴奋的转折事件，我们最近发现，PON 2和脑桥蛋白降解革兰氏阴性细菌密度依赖性传感分子称为酰基高丝氨酸内酯（阿勒）参与革兰氏阴性菌毒力。AHLs是脂内酯。由于革兰氏阴性毒力在炎症性疾病（包括动脉粥样硬化）的病理学中已得到很好的证实，因此我们提出，针对由革兰氏阴性毒力因子（如AHLs）和其他未鉴定的促炎脂内酯介导的促炎途径的保护是PON蛋白的关键生理功能。我们将在PON 2和脑桥转基因/基因敲除小鼠模型中检验这一假设，具体目标是：1）研究PON 2和脑桥在减轻动脉粥样硬化发展中的分子机制和功能; 2）确定PON 2和脑桥是否在宿主防御促炎性群体感应分子和革兰氏阴性菌感染中发挥作用。我们假设PON 2和脑桥是一类新的内酯酶，其降解i）与动脉粥样硬化相关的致动脉粥样硬化脂内酯，和ii）与革兰氏阴性菌相关的促炎酰基高丝氨酸内酯，从而预防炎性疾病的发病机制。